This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Osi Pharmaceuticals, Inc.. Active years: 2011.
Company Filing History:
Years Active: 2011
Title: Ti Wang: Innovator in Pharmaceutical Chemistry
Introduction
Ti Wang is a notable inventor based in Evanston, IL (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that have potential therapeutic applications.
Latest Patents
Ti Wang holds a patent for Furo[3,2-C]pyridines, specifically focusing on Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I. This patent encompasses the preparation, intermediates, pharmaceutical compositions, and uses of these compounds, particularly in the treatment of diseases such as cancers. His work addresses conditions in which epithelial-mesenchymal transition (EMT) is involved, as well as conditions mediated by protein kinase activity, including RON and/or MET.
Career Highlights
Ti Wang is currently associated with Osi Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative work has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Ti Wang has collaborated with notable colleagues, including An-Hu Li and Arno G Steinig, contributing to a dynamic research environment that fosters innovation.
Conclusion
Ti Wang's contributions to pharmaceutical chemistry, particularly through his patent on Furo[3,2-C]pyridines, highlight his role as an influential inventor in the field. His ongoing work at Osi Pharmaceuticals, Inc. continues to pave the way for advancements in disease treatment.